Tian Ruixiang Holdings Ltd (Nasdaq: TIRX), a China-based insurance broker, has announced its plan to acquire Ucare Inc. in an all-stock transaction valued at US$150 million. Ucare operates China's only cloud-based AI-driven platform for hospital and health insurance risk management. This strategic acquisition aims to enhance Tian Ruixiang's capabilities in the rapidly expanding health insurance market in China. By integrating Ucare's advanced AI-driven tools, the company intends to develop differentiated health insurance products, improve distribution within hospital systems, and transition into a data-driven insurance service provider. The transaction, expected to close by July 2025, will see Ucare becoming a wholly-owned subsidiary of VitaCare, a subsidiary of Tian Ruixiang. Ucare's current management, including CEO Mr. Wei Zhu, will remain in place to ensure continuity and growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.